We recently published an article titled Jim Cramer’s Thoughts On These 8 Stocks and the Packaged Goods Playbook. In this ...

The Clorox Company CLX is likely to register a decline in top and bottom lines when it reports second-quarter fiscal 2025 ...

Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. Clorox continues to operate in a challenging macroeconomic environment where consumers face ongoing financial pressures.

Clorox has been benefiting from its IGNITE strategy, which mainly focuses on the expansion of the key elements under the 2020 Strategy to pace up innovation across each area of business.

Clorox has also divested underperforming businesses and reduced operational costs, while ramping up advertising and promotions. President Donald Trump announced new tariffs on imports from Mexico ...

(RTTNews) - While reporting its results for the second quarter, Clorox Company (CLX ... The company now expects net sales to be down 1% to up 2%, including 1 to 2 points of benefit from ...

Even with these investments, we believe Clorox is on the path back to the 44% gross margin levels that have historically characterized the business (up from the low-30s trough in the second ...

In any case, it's added up to tough times for the staples ... That said, I don't see a strong case for owning Clorox shares in particular at the moment. Here's why. Investors who just glanced ...

Consumer products giant Clorox (NYSE:CLX) will be announcing earnings results tomorrow after market hours. Here’s what you need to know. Clorox beat analysts’ revenue expectations by 7.5% last quarter ...

Try Now>> See the top stocks recommended by analysts >> Read More on CLX: Clorox NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle ...

Consumer products giant Clorox (NYSE:CLX) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 15.3% year on year to $1.69 billion. Its non-GAAP profit of $1.55 per ...